C/EBP	B-protein
proteins	I-protein
activate	O
transcription	O
from	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
in	O
macrophages/	O
monocytes	B-cell_type
.	O

Three	O
binding	O
sites	O
for	O
C/EBP	B-protein
proteins	I-protein
are	O
found	O
in	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
(	I-DNA
HIV-1	I-DNA
)	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
(	O
V.M.	O
Tesmer	O
,	O
A.Rajadhyaksha	O
,	O
J.Babin	O
,	O
and	O
M.Bina	O
,	O
Proc.Natl.Acad.Sci.	O
USA	O
90	O
:	O
7298-7302	O
,	O
1993	O
)	O
.	O

We	O
have	O
determined	O
the	O
functional	O
role	O
of	O
C/EBP	B-protein
proteins	I-protein
and	O
C/EBP	B-DNA
sites	I-DNA
in	O
regulating	O
transcription	O
from	O
the	O
HIV-	B-DNA
1	I-DNA
LTR	I-DNA
in	O
monocytes/macrophages	B-cell_type
.	O

Inhibition	O
of	O
endogenous	B-protein
C/EBP	I-protein
proteins	I-protein
,	O
using	O
either	O
an	O
excess	O
of	O
C/EBP	B-DNA
binding	I-DNA
sites	I-DNA
or	O
a	O
trans-	B-DNA
dominant	I-DNA
negative	I-DNA
inhibitor	I-DNA
,	O
demonstrated	O
that	O
C/EBP	B-protein
proteins	I-protein
are	O
required	O
for	O
basal	O
and	O
activated	O
levels	O
of	O
HIV-1	B-DNA
LTR	I-DNA
transcription	O
in	O
the	O
promonocytic	B-cell_line
cell	I-cell_line
line	I-cell_line
U937	I-cell_line
.	O

Northern	O
(	O
RNA	O
)	O
blots	O
and	O
binding	O
assays	O
showed	O
that	O
NF-IL6	B-protein
is	O
the	O
only	O
known	O
C/EBP	B-protein
family	I-protein
member	I-protein
which	O
is	O
increased	O
when	O
U937	B-cell_line
cells	I-cell_line
are	O
activated	O
.	O

Mutational	O
analyses	O
of	O
the	O
HIV-1	B-DNA
LTR	I-DNA
showed	O
that	O
one	O
C/EBP	B-DNA
site	I-DNA
is	O
required	O
for	O
normal	O
LTR	B-DNA
transcription	O
both	O
before	O
and	O
after	O
cellular	O
activation	O
and	O
that	O
the	O
two	O
3	O
'	O
C/EBP	B-DNA
sites	I-DNA
are	O
functionally	O
equivalent	O
.	O

However	O
,	O
transcription	O
from	O
crippled	B-DNA
HIV-1	I-DNA
LTRs	I-DNA
lacking	O
C/EBP	B-DNA
sites	I-DNA
can	O
still	O
be	O
induced	O
following	O
activation	O
of	O
U937	B-cell_line
cells	I-cell_line
.	O

Several	O
models	O
are	O
suggested	O
for	O
how	O
elevated	O
NF-IL6	B-protein
may	O
participate	O
in	O
an	O
autostimulatory	O
loop	O
involving	O
HIV	O
infection	O
,	O
macrophage	O
activation	O
,	O
cytokine	B-protein
expression	O
,	O
and	O
HIV	O
replication	O
.	O

JournaL	NULL
or	NULL
VirRoLOoGY	NULL
,	NULL
Sept.	NULL
1995	NULL
,	NULL
p.	NULL
5337-5344	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

69	NULL
,	NULL
No	NULL
.	NULL

9	NULL
C/EBP	NULL
Proteins	NULL
Activate	NULL
Transcription	NULL
from	NULL
the	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Type	NULL
1	NULL
Long	NULL
Terminal	NULL
Repeat	NULL
in	NULL
Macrophages/Monocytes	NULL
A.	NULL
J.	NULL
HENDERSON	NULL
,	NULL
X.	NULL
ZOU	NULL
,	NULL
anp	NULL
K.	NULL
L.	NULL
CALAME*	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biophysics	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10032	NULL
Received	NULL
3	NULL
October	NULL
1994/Accepted	NULL
17	NULL
May	NULL
1995	NULL
Three	NULL
binding	NULL
sites	NULL
for	NULL
C/EBP	NULL
proteins	NULL
are	NULL
found	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
(	NULL
V.	NULL
M.	NULL
Tesmer	NULL
,	NULL
A.	NULL
Rajadhyaksha	NULL
,	NULL
J.	NULL
Babin	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
,	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7298-7302	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

We	NULL
have	NULL
determined	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
C/EBP	NULL
proteins	NULL
and	NULL
C/EBP	NULL
sites	NULL
in	NULL
regulating	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

Inhibition	NULL
of	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
,	NULL
using	NULL
either	NULL
an	NULL
excess	NULL
of	NULL
C/EBP	NULL
binding	NULL
sites	NULL
or	NULL
a	NULL
frans-dominant	NULL
negative	NULL
inhibitor	NULL
,	NULL
demonstrated	NULL
that	NULL
C/EBP	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
basal	NULL
and	NULL
activated	NULL
levels	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blots	NULL
and	NULL
binding	NULL
assays	NULL
showed	NULL
that	NULL
NF-IL6	NULL
is	NULL
the	NULL
only	NULL
known	NULL
C/EBP	NULL
family	NULL
member	NULL
which	NULL
is	NULL
increased	NULL
when	NULL
U937	NULL
cells	NULL
are	NULL
activated	NULL
.	NULL

Mutational	NULL
analyses	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
showed	NULL
that	NULL
one	NULL
C/EBP	NULL
site	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
LTR	NULL
transcription	NULL
both	NULL
before	NULL
and	NULL
after	NULL
cellular	NULL
activation	NULL
and	NULL
that	NULL
the	NULL
two	NULL
3	NULL
'	NULL
C/EBP	NULL
sites	NULL
are	NULL
functionally	NULL
equivalent	NULL
.	NULL

However	NULL
,	NULL
transcription	NULL
from	NULL
crippled	NULL
HIV-1	NULL
LTRs	NULL
lacking	NULL
C/EBP	NULL
sites	NULL
can	NULL
still	NULL
be	NULL
induced	NULL
following	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

Several	NULL
models	NULL
are	NULL
suggested	NULL
for	NULL
how	NULL
elevated	NULL
NF-IL6	NULL
may	NULL
participate	NULL
in	NULL
an	NULL
autostimulatory	NULL
loop	NULL
involving	NULL
HIV	NULL
infection	NULL
,	NULL
macrophage	NULL
activation	NULL
,	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
HIV	NULL
replication	NULL
.	NULL

Monocytes/macrophages	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
are	NULL
a	NULL
primary	NULL
target	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
.	NULL

Unlike	NULL
HIV-infected	NULL
T	NULL
cells	NULL
,	NULL
HIV-infected	NULL
monocytes/macrophages	NULL
appear	NULL
to	NULL
be	NULL
resistant	NULL
to	NULL
the	NULL
cytopathic	NULL
effects	NULL
of	NULL
the	NULL
virus	NULL
and	NULL
thus	NULL
serve	NULL
as	NULL
a	NULL
reservoir	NULL
for	NULL
persistent	NULL
infection	NULL
and	NULL
virus	NULL
dissemination	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

HIV-infected	NULL
monocytes/macrophages	NULL
are	NULL
also	NULL
associated	NULL
with	NULL
the	NULL
AIDS-related	NULL
pathologies	NULL
observed	NULL
in	NULL
the	NULL
lungs	NULL
,	NULL
skin	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
and	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
9	NULL
,	NULL
16	NULL
,	NULL
18	NULL
,	NULL
23	NULL
,	NULL
24	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
AIDS	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
HIV	NULL
expression	NULL
in	NULL
monocytes/	NULL
macrophages	NULL
has	NULL
not	NULL
been	NULL
extensively	NULL
studied	NULL
.	NULL

Inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
interleukin	NULL
1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
are	NULL
elevated	NULL
in	NULL
patients	NULL
with	NULL
AIDS	NULL
,	NULL
and	NULL
these	NULL
cytokines	NULL
mediate	NULL
activation	NULL
and	NULL
differentiation	NULL
of	NULL
monocytes/macrophages	NULL
(	NULL
5	NULL
,	NULL
15	NULL
,	NULL
25	NULL
,	NULL
27	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
relationship	NULL
between	NULL
HIV	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
infection	NULL
,	NULL
macrophage	NULL
activation	NULL
,	NULL
induction	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
HIV-1	NULL
replication	NULL
is	NULL
not	NULL
known	NULL
,	NULL
but	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
macrophages	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
HIV-1	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
an	NULL
autostimulatory	NULL
loop	NULL
.	NULL

Activation	NULL
of	NULL
macrophages	NULL
induces	NULL
an	NULL
array	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
NF-kB/rel	NULL
and	NULL
NF-IL6	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
activate	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

NF-	NULL
«	NULL
B/rel	NULL
proteins	NULL
also	NULL
activate	NULL
HIV-1	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
the	NULL
function	NULL
of	NULL
C/EBP	NULL
proteins	NULL
for	NULL
regulation	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
monocytes/macrophages	NULL
is	NULL
not	NULL
known	NULL
.	NULL

NF-IL6	NULL
is	NULL
a	NULL
strong	NULL
transcriptional	NULL
activator	NULL
that	NULL
is	NULL
induced	NULL
during	NULL
monocyte/macrophage	NULL
differentiation	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
37	NULL
)	NULL
.	NULL

NF-IL6	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
several	NULL
cellular	NULL
genes	NULL
which	NULL
are	NULL
expressed	NULL
in	NULL
activated	NULL
monocytes	NULL
,	NULL
including	NULL
genes	NULL
encoding	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
granulocyte	NULL
colony	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbi-ology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
&	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
701	NULL
W.	NULL
168th	NULL
St.	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10032	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
212	NULL
)	NULL
305-3504	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
212	NULL
)	NULL
305-1468	NULL
.	NULL

5337	NULL
stimulating	NULL
factor	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
demonstrated	NULL
that	NULL
it	NULL
is	NULL
necessary	NULL
for	NULL
normal	NULL
macrophage	NULL
bactericidal	NULL
and	NULL
tumoricidal	NULL
functions	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
NF-IL6	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
three	NULL
sites	NULL
on	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
could	NULL
also	NULL
be	NULL
important	NULL
for	NULL
HIV-1	NULL
transcription	NULL
in	NULL
monocytes/	NULL
macrophages	NULL
(	NULL
58	NULL
)	NULL
.	NULL

NF-IL6	NULL
(	NULL
C/EBPB	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
also	NULL
includes	NULL
activators	NULL
C/EBP	NULL
(	NULL
C/	NULL
EBPa	NULL
)	NULL
,	NULL
CRP3	NULL
(	NULL
C/EBP38	NULL
)	NULL
,	NULL
and	NULL
CRP1	NULL
and	NULL
negative	NULL
regulators	NULL
liver	NULL
inhibitory	NULL
protein	NULL
(	NULL
LIP	NULL
)	NULL
,	NULL
Ig/EBP	NULL
(	NULL
C/EBPy	NULL
)	NULL
,	NULL
and	NULL
CHOP-10	NULL
(	NULL
2	NULL
,	NULL
6	NULL
,	NULL
13	NULL
,	NULL
47	NULL
,	NULL
48	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Family	NULL
members	NULL
share	NULL
homology	NULL
in	NULL
their	NULL
basic	NULL
leucine	NULL
zipper	NULL
regions	NULL
and	NULL
as	NULL
a	NULL
result	NULL
recognize	NULL
the	NULL
same	NULL
DNA	NULL
consensus	NULL
sequence	NULL
and	NULL
can	NULL
form	NULL
heterodimers	NULL
with	NULL
one	NULL
another	NULL
(	NULL
61	NULL
)	NULL
.	NULL

C/EBP	NULL
sites	NULL
occur	NULL
in	NULL
regulatory	NULL
regions	NULL
of	NULL
many	NULL
cytokine	NULL
genes	NULL
,	NULL
liver-specific	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
acute-phase	NULL
proteins	NULL
,	NULL
immunoglobulin	NULL
heavy-	NULL
and	NULL
light-chain	NULL
genes	NULL
,	NULL
and	NULL
several	NULL
viruses	NULL
in	NULL
addition	NULL
to	NULL
HIV-1	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
addressed	NULL
the	NULL
functional	NULL
role	NULL
that	NULL
C/EBP	NULL
family	NULL
proteins	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
play	NULL
in	NULL
regulating	NULL
transcription	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
the	NULL
human	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
chosen	NULL
for	NULL
this	NULL
study	NULL
because	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
mediators	NULL
such	NULL
as	NULL
lipo-polysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
induces	NULL
cellular	NULL
differentiation	NULL
(	NULL
22	NULL
,	NULL
37	NULL
,	NULL
46	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
C/EBP	NULL
proteins	NULL
are	NULL
important	NULL
activators	NULL
of	NULL
HIV-1	NULL
transcription	NULL
both	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
and	NULL
that	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
normal	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
activity	NULL
.	NULL

NF-IL6	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
key	NULL
C/EBP	NULL
family	NULL
activator	NULL
for	NULL
the	NULL
HIV-1	NULL
LTR	NULL
since	NULL
it	NULL
is	NULL
the	NULL
only	NULL
family	NULL
member	NULL
which	NULL
is	NULL
induced	NULL
upon	NULL
LPS-PMA	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Plasmids	NULL
.	NULL

The	NULL
500-bp	NULL
Bg/lI	NULL
fragment	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
from	NULL
strain	NULL
HXB2	NULL
(	NULL
49	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
SmeI	NULL
site	NULL
located	NULL
5	NULL
'	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
LUC	NULL
)	NULL
in	NULL
the	NULL
p19LUC	NULL
vector	NULL
(	NULL
60	NULL
)	NULL
.	NULL

The	NULL
-158ALTR	NULL
construct	NULL
was	NULL
generated	NULL
by	NULL
5338	NULL
HENDERSON	NULL
ET	NULL
AL	NULL
.	NULL

subcloning	NULL
the	NULL
178-bp	NULL
Aval-Bg/lI	NULL
fragment	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
p19LUC	NULL
.	NULL

The	NULL
m	NULL
«	NULL
B	NULL
HIV	NULL
LTR-LUC	NULL
construct	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
Bgill	NULL
fragment	NULL
from	NULL
m	NULL
«	NULL
B-CAT	NULL
,	NULL
generously	NULL
provided	NULL
by	NULL
G.	NULL
Nabel	NULL
(	NULL
University	NULL
of	NULL
Michigan	NULL
)	NULL
(	NULL
35	NULL
)	NULL
,	NULL
into	NULL
p19LUC	NULL
as	NULL
described	NULL
above	NULL
.	NULL

For	NULL
the	NULL
-93ALTR	NULL
construct	NULL
,	NULL
the	NULL
117-bp	NULL
Accl-Bgill	NULL
fragment	NULL
from	NULL
m	NULL
«	NULL
BLTRCAT	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
p19LUC	NULL
.	NULL

The	NULL
deletion	NULL
mutations	NULL
-205ALTR	NULL
and	NULL
-109ALTR	NULL
and	NULL
the	NULL
site-directed	NULL
mutations	NULL
mC2LTR	NULL
and	NULL
mC3LTR	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
(	NULL
28	NULL
,	NULL
42	NULL
)	NULL
using	NULL
oligonucleotides	NULL
-205A	NULL
(	NULL
5	NULL
'	NULL
AGAGAAGCTTTAGAGTGGAGG	NULL
3	NULL
``	NULL
)	NULL
,	NULL
-109A	NULL
(	NULL
5°	NULL
GACATCGAAGCTTGGGACTTTCCGCT	NULL
3	NULL
``	NULL
)	NULL
,	NULL
mC3	NULL
(	NULL
5°GCTGA	NULL
CATCGACAGCTGTACAAGGGAC	NULL
3	NULL
)	NULL
,	NULL
mC2	NULL
(	NULL
5	NULL
GCCGCCTAGCTGCAG	NULL
GGGCGTGGCCCGAGAG	NULL
3	NULL
)	NULL
,	NULL
and	NULL
3'LTR	NULL
(	NULL
5	NULL
)	NULL
CCACTGCTAGAGATTITTC	NULL
CAC	NULL
3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
pI9LUC	NULL
.	NULL

The	NULL
mC2,3	NULL
double	NULL
mutation	NULL
was	NULL
also	NULL
generated	NULL
by	NULL
PCR	NULL
,	NULL
but	NULL
the	NULL
mC2LTR	NULL
construct	NULL
rather	NULL
than	NULL
the	NULL
wild-type	NULL
LTR	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
in	NULL
the	NULL
PCRs	NULL
.	NULL

Mutations	NULL
were	NULL
confirmed	NULL
by	NULL
restriction	NULL
analysis	NULL
and	NULL
sequencing	NULL
.	NULL

The	NULL
expression	NULL
vectors	NULL
for	NULL
rat	NULL
NF-IL6	NULL
,	NULL
LIP	NULL
,	NULL
and	NULL
Ig/EBP	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
11	NULL
,	NULL
13	NULL
)	NULL
.	NULL

pUC-E4	NULL
was	NULL
generated	NULL
by	NULL
cloning	NULL
four	NULL
tandem	NULL
C/EBP	NULL
binding	NULL
sites	NULL
into	NULL
pUC19	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Transfections	NULL
.	NULL

For	NULL
transfection	NULL
experiments	NULL
,	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
0.3	NULL
ml	NULL
of	NULL
U937	NULL
cells	NULL
resuspended	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
at	NULL
1.0	NULL
X	NULL
10	NULL
``	NULL
to	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
cell	NULL
suspensions	NULL
were	NULL
electroporated	NULL
by	NULL
pulsing	NULL
with	NULL
960	NULL
F	NULL
and	NULL
240	NULL
V	NULL
from	NULL
a	NULL
Bio-Rad	NULL
(	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
Gene	NULL
Pulser	NULL
apparatus	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
for	NULL
24	NULL
h	NULL
before	NULL
harvesting	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

At	NULL
the	NULL
time	NULL
of	NULL
harvesting	NULL
,	NULL
cells	NULL
were	NULL
counted	NULL
and	NULL
luciferase	NULL
values	NULL
were	NULL
corrected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
counts	NULL
.	NULL

At	NULL
least	NULL
three	NULL
independent	NULL
plasmid	NULL
preparations	NULL
were	NULL
tested	NULL
for	NULL
each	NULL
construct	NULL
,	NULL
and	NULL
all	NULL
transfections	NULL
were	NULL
done	NULL
in	NULL
at	NULL
least	NULL
duplicate	NULL
.	NULL

Transfection	NULL
efficiencies	NULL
in	NULL
some	NULL
experiments	NULL
were	NULL
controlled	NULL
by	NULL
cotransfecting	NULL
a	NULL
human	NULL
growth	NULL
hormone	NULL
expression	NULL
vector	NULL
,	NULL
pXGHS	NULL
(	NULL
Nichols	NULL
Institute	NULL
Diagnostics	NULL
,	NULL
San	NULL
Juan	NULL
Capistrano	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

For	NULL
luciferase	NULL
quantitation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
25	NULL
mM	NULL
glycylglycine	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
15	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
4	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
.	NULL

To	NULL
assay	NULL
for	NULL
luciferase	NULL
activity	NULL
,	NULL
500	NULL
pl	NULL
of	NULL
reaction	NULL
buffer	NULL
(	NULL
15	NULL
mM	NULL
KPO	NULL
,	NULL
buffer	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
2	NULL
mM	NULL
ATP	NULL
[	NULL
pH	NULL
7.0	NULL
]	NULL
,	NULL
25	NULL
mM	NULL
glycylglycine	NULL
,	NULL
15	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
4	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
)	NULL
and	NULL
100	NULL
pl	NULL
of	NULL
substrate	NULL
buffer	NULL
(	NULL
0.4	NULL
mM	NULL
luciferin	NULL
,	NULL
25	NULL
mM	NULL
glycylglycine	NULL
,	NULL
15	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
4	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
)	NULL
were	NULL
added	NULL
to	NULL
100	NULL
pl	NULL
of	NULL
the	NULL
supernatant	NULL
.	NULL

Samples	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
lumi-nometer	NULL
.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
blots	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
lysing	NULL
cells	NULL
with	NULL
4	NULL
M	NULL
guanidium	NULL
isothiocyanate-25	NULL
mM	NULL
sodium	NULL
citrate-0.5	NULL
%	NULL
n-lauryl	NULL
sarcosine-100	NULL
mM	NULL
mercaptocthanol	NULL
.	NULL

Lysates	NULL
were	NULL
pelleted	NULL
through	NULL
a	NULL
5.7	NULL
M	NULL
CsCl	NULL
cushion	NULL
by	NULL
centrifugation	NULL
for	NULL
12	NULL
h	NULL
at	NULL
36,000	NULL
rpm	NULL
in	NULL
an	NULL
SW50	NULL
rotor	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Forty	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
resuspended	NULL
in	NULL
1	NULL
%	NULL
formaldehyde	NULL
gel-buffer	NULL
(	NULL
0.1	NULL
M	NULL
morpho-linepropanesulfonic	NULL
acid	NULL
[	NULL
MOPS	NULL
;	NULL
pH	NULL
7.0	NULL
]	NULL
,	NULL
40	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
)	NULL
-17.5	NULL
%	NULL
formaldehyde-50	NULL
%	NULL
formamide-1	NULL
x	NULL
gel-loading	NULL
buffer	NULL
(	NULL
50	NULL
%	NULL
glye-erol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.25	NULL
%	NULL
bromophenol	NULL
blue	NULL
,	NULL
0.25	NULL
%	NULL
xylene	NULL
cyanol	NULL
FF	NULL
)	NULL
and	NULL
separated	NULL
on	NULL
a	NULL
formaldehyde-agarose	NULL
gel	NULL
(	NULL
1	NULL
%	NULL
agarose	NULL
,	NULL
1	NULL
%	NULL
formaldehyde	NULL
gel	NULL
buffer	NULL
,	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
)	NULL
(	NULL
32	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
transferred	NULL
to	NULL
Hybond-N	NULL
nylon	NULL
membranes	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IIl	NULL
.	NULL
)	NULL

by	NULL
capillary	NULL
action	NULL
,	NULL
using	NULL
20	NULL
%	NULL
SSC	NULL
(	NULL
3	NULL
M	NULL
NaCl	NULL
,	NULL
0.3	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
(	NULL
32	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
fixed	NULL
to	NULL
the	NULL
membrane	NULL
by	NULL
baking	NULL
for	NULL
2	NULL
h	NULL
at	NULL
80°C	NULL
and	NULL
hybridized	NULL
with	NULL
radiolabeled	NULL
probes	NULL
at	NULL
65°C	NULL
in	NULL
1.5	NULL
%	NULL
SSPE	NULL
(	NULL
0.23	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
x	NULL
M	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
1.5	NULL
x	NULL
10~	NULL
M	NULL
EDTA	NULL
)	NULL
-10	NULL
%	NULL
polyethelene	NULL
glycol-7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-0.1	NULL
ug	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
per	NULL
ml	NULL
for	NULL
at	NULL
least	NULL
12	NULL
h.	NULL
Filters	NULL
were	NULL
washed	NULL
once	NULL
at	NULL
22°C	NULL
in	NULL
2	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
,	NULL
once	NULL
at	NULL
65°C	NULL
in	NULL
1	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
once	NULL
at	NULL
65°C	NULL
in	NULL
0.3	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Filters	NULL
were	NULL
stripped	NULL
by	NULL
washing	NULL
at	NULL
100°C	NULL
in	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
with	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
>	NULL
2	NULL
X	NULL
10	NULL
``	NULL
were	NULL
generated	NULL
by	NULL
random	NULL
priming	NULL
gel-isolated	NULL
DNA	NULL
fragments	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
.	NULL

EMSAs	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
2	NULL
to	NULL
4	NULL
g	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
or	NULL
1	NULL
pg	NULL
of	NULL
protein	NULL
from	NULL
extracts	NULL
of	NULL
bacteria	NULL
expressing	NULL
recombinant	NULL
rat	NULL
NF-IL6	NULL
,	NULL
25	NULL
mM	NULL
N-2-hydroxyethylpiperazine-V'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
7.5	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.75	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
MgCl	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
preincubated	NULL
with	NULL
specific	NULL
and	NULL
nonspecific	NULL
competitors	NULL
and	NULL
polyclonal	NULL
antisera	NULL
(	NULL
12	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
of	NULL
10°	NULL
cpm	NULL
of	NULL
probe	NULL
and	NULL
incubation	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
directly	NULL
onto	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
electrophoresed	NULL
at	NULL
120	NULL
V	NULL
in	NULL
1	NULL
%	NULL
Tris-borate-EDTA	NULL
.	NULL

Probes	NULL
for	NULL
EMSA	NULL
were	NULL
generated	NULL
by	NULL
using	NULL
oligonucleotides	NULL
representing	NULL
the	NULL
C/EBP	NULL
site	NULL
that	NULL
spans	NULL
-169	NULL
bp	NULL
(	NULL
5	NULL
'	NULL
GATCGCCTAGCATTTCATCACA	NULL
CGT	NULL
3	NULL
'	NULL
and	NULL
5°	NULL
GATCACGTGTGATGAAATGCTAGGC	NULL
3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Probes	NULL
were	NULL
generated	NULL
by	NULL
end	NULL
filling	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
Escherichia	NULL
coli	NULL
polymerase	NULL
(	NULL
32	NULL
)	NULL
or	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
kinase-treated	NULL
oligonucleotide	NULL
(	NULL
26	NULL
)	NULL
.	NULL

For	NULL
DNase	NULL
I	NULL
footprinting	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
bacterially	NULL
expressed	NULL
rat	NULL
NF-IL6	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
dI-dC	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
7.5	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.75	NULL
mM	NULL
DTT	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
10*	NULL
cpm	NULL
of	NULL
probe	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
J.	NULL
ViroL	NULL
.	NULL

10	NULL
9	NULL
8	NULL
7	NULL
4	NULL
6	NULL
4	NULL
3	NULL
2	NULL
_	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
&	NULL
n	NULL
L	NULL
1	NULL
-	NULL
<	NULL
ug	NULL
of	NULL
pUCE4	NULL
plasmid	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Basal	NULL
and	NULL
activated	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
is	NULL
decreased	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
LTR-LUC	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
pUC-E4	NULL
,	NULL
a	NULL
plasmid	NULL
with	NULL
four	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

pUC19	NULL
was	NULL
used	NULL
to	NULL
ensure	NULL
that	NULL
all	NULL
transfection	NULL
mixtures	NULL
had	NULL
a	NULL
total	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
DNA	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
@	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
#	NULL
)	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
LPS	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
error	NULL
bars	NULL
show	NULL
1	NULL
standard	NULL
deviation	NULL
.	NULL

22°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Following	NULL
binding	NULL
,	NULL
0.1	NULL
U	NULL
of	NULL
RQ1	NULL
DNase	NULL
I	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
diluted	NULL
in	NULL
25	NULL
mM	NULL
CaCl	NULL
,	NULL
was	NULL
added	NULL
to	NULL
each	NULL
reaction	NULL
mixture	NULL
,	NULL
and	NULL
the	NULL
mixtures	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
min	NULL
at	NULL
22°C	NULL
(	NULL
64	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
100	NULL
pl	NULL
of	NULL
stop	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
20	NULL
mM	NULL
EDTA	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
24:1	NULL
chloroform-isoamyl	NULL
alcohol	NULL
,	NULL
precipitated	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
sequencing	NULL
gel	NULL
with	NULL
G	NULL
and	NULL
G+A	NULL
ladders	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

End-labeled	NULL
probes	NULL
for	NULL
DNase	NULL
I	NULL
footprinting	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
a	NULL
kinase-labeled	NULL
-205A	NULL
oligonucleotide	NULL
and	NULL
cither	NULL
the	NULL
wild-type	NULL
LTR	NULL
or	NULL
the	NULL
mC2,3LTR	NULL
construct	NULL
as	NULL
a	NULL
template	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Following	NULL
PCRs	NULL
,	NULL
probes	NULL
were	NULL
gel	NULL
purified	NULL
.	NULL

RESULTS	NULL
Endogenous	NULL
C/EBP	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

NF-IL6	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
coordinate	NULL
regulation	NULL
of	NULL
several	NULL
genes	NULL
expressed	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

Previous	NULL
studies	NULL
,	NULL
as	NULL
well	NULL
as	NULL
our	NULL
own	NULL
experiments	NULL
,	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-IL6	NULL
can	NULL
bind	NULL
three	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
reference	NULL
58	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NF-IL6	NULL
can	NULL
transactivate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
the	NULL
variety	NULL
of	NULL
cells	NULL
,	NULL
including	NULL
monocytes/macrophages	NULL
(	NULL
reference	NULL
58	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
indicate	NULL
that	NULL
NF-IL6	NULL
can	NULL
activate	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
a	NULL
cotransfection	NULL
assay	NULL
,	NULL
they	NULL
do	NULL
not	NULL
address	NULL
the	NULL
role	NULL
that	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
may	NULL
play	NULL
in	NULL
HIV-1	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
that	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
play	NULL
in	NULL
regulating	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
in	NULL
monocytes/macrophages	NULL
,	NULL
we	NULL
used	NULL
two	NULL
different	NULL
strategies	NULL
,	NULL
both	NULL
of	NULL
which	NULL
depended	NULL
on	NULL
functional	NULL
inhibition	NULL
of	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
.	NULL

First	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
HIV-1	NULL
LTR-LUC	NULL
reporter	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
control	NULL
pUC19	NULL
vector	NULL
or	NULL
pUC-E4	NULL
,	NULL
a	NULL
vector	NULL
that	NULL
contains	NULL
four	NULL
C/EBP	NULL
binding	NULL
sites	NULL
(	NULL
3	NULL
)	NULL
and	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
bind	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
the	NULL
U937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
LPS	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
24	NULL
h.	NULL
Activation	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
22	NULL
,	NULL
37	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
pUC-E4	NULL
diminished	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
by	NULL
approximately	NULL
70	NULL
%	NULL
prior	NULL
to	NULL
LPS-PMA	NULL
treatment	NULL
.	NULL

After	NULL
U937	NULL
cell	NULL
activation	NULL
,	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
was	NULL
inhibited	NULL
by	NULL
80	NULL
%	NULL
at	NULL
the	NULL
highest	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
1	NULL
T	NULL
T	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
ug	NULL
of	NULL
LIP	NULL
Vector	NULL
Relative	NULL
Light	NULL
Units	NULL
TK200-LUC	NULL
pCMV-LUC	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Basal	NULL
and	NULL
activated	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
trans-dominant	NULL
negative	NULL
protein	NULL
LIP	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Untreated	NULL
(	NULL
N	NULL
)	NULL
and	NULL
LPS-PMA-treated	NULL
(	NULL
@	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
LTR-LUC	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
CMV-LIP	NULL
expression	NULL
vector	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
pCMV-LUC	NULL
or	NULL
5	NULL
mg	NULL
of	NULL
TK200-LUC	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
CMV-LIP	NULL
expression	NULL
(	NULL
stippled	NULL
bars	NULL
)	NULL
vector	NULL
or	NULL
pCMV	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
.	NULL

pCMV	NULL
was	NULL
used	NULL
to	NULL
ensure	NULL
that	NULL
all	NULL
transfections	NULL
had	NULL
a	NULL
total	NULL
of	NULL
10	NULL
g	NULL
of	NULL
CMV	NULL
promoter	NULL
.	NULL

The	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
error	NULL
bars	NULL
show	NULL
1	NULL
standard	NULL
deviation	NULL
.	NULL

concentration	NULL
of	NULL
pUC-E4	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
endogenous	NULL
C/EBP	NULL
-binding	NULL
proteins	NULL
are	NULL
important	NULL
for	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
U937	NULL
cells	NULL
both	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
LPS	NULL
and	NULL
PMA	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
corroborated	NULL
by	NULL
experiments	NULL
using	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
LIP	NULL
,	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
NF-IL6	NULL
which	NULL
acts	NULL
as	NULL
a	NULL
frans-dominant	NULL
negative	NULL
regulator	NULL
of	NULL
C/EBP	NULL
family	NULL
activators	NULL
,	NULL
including	NULL
C/EBP	NULL
and	NULL
NF-IL6	NULL
(	NULL
13	NULL
)	NULL
.	NULL

LIP	NULL
contains	NULL
the	NULL
conserved	NULL
basic	NULL
leucine	NULL
zipper	NULL
domain	NULL
which	NULL
permits	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
but	NULL
lacks	NULL
a	NULL
strong	NULL
transcriptional	NULL
activation	NULL
domain	NULL
;	NULL
therefore	NULL
,	NULL
inactive	NULL
LIP-containing	NULL
heterodimers	NULL
can	NULL
form	NULL
between	NULL
LIP	NULL
and	NULL
C/EBP	NULL
activators	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
a	NULL
LIP	NULL
expression	NULL
vector	NULL
inhibited	NULL
HIV-1	NULL
LTR-dependent	NULL
transcription	NULL
both	NULL
before	NULL
and	NULL
after	NULL
LPS-PMA	NULL
differentiation	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
inhibition	NULL
was	NULL
not	NULL
C/EBP	NULL
PROTEINS	NULL
REGULATE	NULL
THE	NULL
HIV-1	NULL
LTR	NULL
5339	NULL
D	NULL
D	NULL
kel	NULL
<	NULL
<	NULL
o	NULL
ig	NULL
|g	NULL
Ig	NULL
ig	NULL
o	NULL
o	NULL
&	NULL
o	NULL
&	NULL
6	NULL
&	NULL
5	NULL
%	NULL
Rox	NULL
®	NULL
S	NULL
E	NULL
9	NULL
P	NULL
g	NULL
E	NULL
g	NULL
3	NULL
g	NULL
5	NULL
%	NULL
5	NULL
%	NULL
5	NULL
=	NULL
%	NULL
5	NULL
%	NULL
C/EBP	NULL
d	NULL
<	NULL
NF-IL6	NULL
.	NULL

cars	NULL
MW®	NULL
ig/EBP	NULL
gactin	NULL
|	NULL
NB	NULL
be	NULL
#	NULL
ie	NULL
#	NULL
#	NULL
a	NULL
io	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Expression	NULL
of	NULL
C/EBP	NULL
family	NULL
members	NULL
before	NULL
and	NULL
after	NULL
U937	NULL
differentiation	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
24	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

due	NULL
to	NULL
nonspecific	NULL
inhibition	NULL
of	NULL
transcription	NULL
by	NULL
LIP	NULL
because	NULL
cotransfecting	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
-LIP	NULL
construct	NULL
with	NULL
luciferase	NULL
reporters	NULL
driven	NULL
by	NULL
the	NULL
CMV	NULL
promoter	NULL
or	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
k	NULL
promoter	NULL
did	NULL
not	NULL
reduce	NULL
their	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
second	NULL
negative	NULL
regulator	NULL
of	NULL
C/EBP	NULL
activators	NULL
,	NULL
Ig/EBP	NULL
(	NULL
11	NULL
)	NULL
,	NULL
also	NULL
inhibited	NULL
LTR	NULL
activity	NULL
following	NULL
U937	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
show	NULL
that	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
are	NULL
necessary	NULL
for	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
U937	NULL
promonocytes	NULL
both	NULL
before	NULL
and	NULL
after	NULL
activation	NULL
.	NULL

NF-IL6	NULL
is	NULL
the	NULL
only	NULL
C/EBP	NULL
family	NULL
member	NULL
whose	NULL
levels	NULL
are	NULL
increased	NULL
upon	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
above	NULL
indicated	NULL
that	NULL
C/EBP	NULL
family	NULL
members	NULL
are	NULL
required	NULL
for	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
but	NULL
did	NULL
not	NULL
distinguish	NULL
which	NULL
family	NULL
members	NULL
might	NULL
be	NULL
responsible	NULL
for	NULL
this	NULL
transcriptional	NULL
activation	NULL
.	NULL

Therefore	NULL
,	NULL
mRNA	NULL
levels	NULL
of	NULL
four	NULL
C/EBP	NULL
family	NULL
members	NULL
,	NULL
NF-IL6	NULL
,	NULL
C/EBP	NULL
,	NULL
CRP3	NULL
,	NULL
and	NULL
Ig/EBP	NULL
,	NULL
were	NULL
examined	NULL
to	NULL
gain	NULL
insight	NULL
into	NULL
their	NULL
regulation	NULL
during	NULL
monocyte	NULL
differentiation	NULL
.	NULL

C/EBP	NULL
,	NULL
NF-IL6	NULL
,	NULL
and	NULL
CRP3	NULL
are	NULL
transcriptional	NULL
activators	NULL
,	NULL
while	NULL
Ig/EBP	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
these	NULL
activators	NULL
(	NULL
2	NULL
,	NULL
6	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
47	NULL
,	NULL
63	NULL
)	NULL
.	NULL

mRNA	NULL
for	NULL
CRP3	NULL
and	NULL
Ig/EBP	NULL
was	NULL
detected	NULL
at	NULL
modest	NULL
levels	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
and	NULL
these	NULL
levels	NULL
did	NULL
not	NULL
change	NULL
following	NULL
activation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
C/EBP	NULL
mRNA	NULL
levels	NULL
were	NULL
reduced	NULL
2-fold	NULL
and	NULL
NF-IL6	NULL
mRNA	NULL
levels	NULL
were	NULL
increased	NULL
15-fold	NULL
following	NULL
U937	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
37	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
mRNAs	NULL
encoding	NULL
three	NULL
activators	NULL
which	NULL
recognize	NULL
C/EBP	NULL
sites-C/EBP	NULL
,	NULL
CRP3	NULL
,	NULL
and	NULL
NF-IL6-are	NULL
present	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

C/EBP	NULL
and	NULL
CRP3	NULL
are	NULL
present	NULL
before	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
NF-IL6	NULL
is	NULL
the	NULL
only	NULL
family	NULL
member	NULL
whose	NULL
mRNA	NULL
is	NULL
induced	NULL
by	NULL
treatment	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
either	NULL
heterodimers	NULL
or	NULL
homodimers	NULL
of	NULL
C/EBP	NULL
and	NULL
CRP3	NULL
are	NULL
responsible	NULL
for	NULL
activating	NULL
the	NULL
HIV	NULL
LTR	NULL
via	NULL
the	NULL
C/EBP	NULL
sites	NULL
prior	NULL
to	NULL
cell	NULL
activation	NULL
and	NULL
that	NULL
NF-IL6	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
following	NULL
activation	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
to	NULL
examine	NULL
proteins	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
which	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
HIV-1	NULL
C/EBP	NULL
sites	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
and	NULL
LPS-PMA-stimulated	NULL
U937	NULL
cells	NULL
.	NULL

Using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
representing	NULL
the	NULL
C/EBP	NULL
site	NULL
which	NULL
spans	NULL
the	NULL
-169	NULL
bp	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
a	NULL
weak	NULL
complex	NULL
,	NULL
presumably	NULL
due	NULL
to	NULL
C/EBP	NULL
,	NULL
CRP3	NULL
,	NULL
and	NULL
Ig/EBP	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
was	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
U937	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
complex	NULL
increased	NULL
approximately	NULL
fivefold	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
LPS-PMA-stimulated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
C/EBP	NULL
site	NULL
competitors	NULL
but	NULL
not	NULL
by	NULL
heterologous	NULL
competitors	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
and	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
complex	NULL
was	NULL
ablated	NULL
when	NULL
an	NULL
NF-IL6	NULL
polyclonal	NULL
antiserum	NULL
was	NULL
included	NULL
in	NULL
the	NULL
EMSA	NULL
reaction	NULL
mixture	NULL
,	NULL
demonstrating	NULL
that	NULL
NF-IL6	NULL
is	NULL
a	NULL
major	NULL
component	NULL
of	NULL
the	NULL
C/EBP	NULL
site	NULL
complex	NULL
in	NULL
activated	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
binding	NULL
data	NULL
5340	NULL
HENDERSON	NULL
ET	NULL
AL	NULL
.	NULL

50ug	NULL
N.S	NULL
.	NULL

50ug	NULL
E4	NULL
w	NULL
=	NULL
Be	NULL
@	NULL
50ug	NULL
E4	NULL
Competitor	NULL
_	NULL
__	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Untreated	NULL
_	NULL
LPS/PMA	NULL
Treated	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

LPS-PMA	NULL
stimulation	NULL
increases	NULL
binding	NULL
of	NULL
NF-IL6	NULL
to	NULL
the	NULL
HIV-1	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
unstimulated	NULL
and	NULL
LPS-PMA-stimulated	NULL
U937	NULL
cells	NULL
and	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
which	NULL
spans	NULL
the	NULL
-169	NULL
bp	NULL
C/EBP	NULL
binding	NULL
site	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
no	NULL
competitor	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
unrelated	NULL
(	NULL
nonspecific	NULL
[	NULL
N.S	NULL
.	NULL
]	NULL

)	NULL
GATA	NULL
competitors	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
specific	NULL
C/EBP	NULL
binding-site	NULL
competitor	NULL
(	NULL
lane	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
preimmune	NULL
(	NULL
PT	NULL
)	NULL
serum	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
an	NULL
NF-IL6	NULL
polyclonal	NULL
antiserum	NULL
(	NULL
aNF-IL6	NULL
)	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

are	NULL
consistent	NULL
with	NULL
the	NULL
mRNA	NULL
steady-state	NULL
levels	NULL
and	NULL
demonstrate	NULL
that	NULL
C/EBP	NULL
proteins	NULL
which	NULL
bind	NULL
the	NULL
HIV-1	NULL
LTR	NULL
increase	NULL
following	NULL
activation	NULL
and	NULL
that	NULL
this	NULL
change	NULL
is	NULL
due	NULL
primarily	NULL
to	NULL
increased	NULL
NF-IL6	NULL
.	NULL

One	NULL
C/EBP	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
HIV	NULL
LTR	NULL
transcription	NULL
in	NULL
quiescent	NULL
U937	NULL
cells	NULL
.	NULL

Tesmer	NULL
et	NULL
al	NULL
.	NULL

tested	NULL
the	NULL
function	NULL
of	NULL
an	NULL
HIV-1	NULL
LTR	NULL
containing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
highest-affinity	NULL
C/EBP	NULL
binding	NULL
site	NULL
and	NULL
found	NULL
that	NULL
it	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
NF-IL6	NULL
to	NULL
transactivate	NULL
(	NULL
58	NULL
)	NULL
.	NULL

However	NULL
,	NULL
their	NULL
mutant	NULL
reporter	NULL
still	NULL
contained	NULL
two	NULL
wild-type	NULL
C/EBP	NULL
sites	NULL
.	NULL

We	NULL
wished	NULL
to	NULL
determine	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
three	NULL
C/EBP	NULL
sites	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
examine	NULL
whether	NULL
(	NULL
i	NULL
)	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
three	NULL
C/EBP	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
sites	NULL
are	NULL
functionally	NULL
equivalent	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
one	NULL
or	NULL
more	NULL
C/EBP	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
when	NULL
U937	NULL
cells	NULL
are	NULL
activated	NULL
by	NULL
LPS	NULL
and	NULL
PMA	NULL
.	NULL

To	NULL
address	NULL
these	NULL
questions	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
truncation	NULL
mutations	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
and	NULL
tested	NULL
their	NULL
transcriptional	NULL
activity	NULL
by	NULL
transfection	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
two	NULL
most	NULL
5	NULL
'	NULL
C/EBP	NULL
sites	NULL
did	NULL
not	NULL
decrease	NULL
transcription	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
construct	NULL
in	NULL
cells	NULL
prior	NULL
to	NULL
LPS-PMA	NULL
treatment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
the	NULL
-205ALTR	NULL
construct	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
C/EBP	NULL
binding	NULL
sites	NULL
,	NULL
is	NULL
as	NULL
active	NULL
as	NULL
the	NULL
full-length	NULL
HIV-1	NULL
LTR	NULL
,	NULL
whereas	NULL
the	NULL
-158ALTR	NULL
construct	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
single	NULL
C/EBP	NULL
site	NULL
,	NULL
is	NULL
slightly	NULL
more	NULL
active	NULL
than	NULL
the	NULL
wild-type	NULL
LTR	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
all	NULL
three	NULL
C/EBP	NULL
sites	NULL
(	NULL
the	NULL
-109ALTR	NULL
construct	NULL
)	NULL
reduced	NULL
transcription	NULL
approximately	NULL
fivefold	NULL
even	NULL
though	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
the	NULL
three	NULL
Sp1	NULL
sites	NULL
remained	NULL
.	NULL

A	NULL
similar	NULL
decrease	NULL
was	NULL
observed	NULL
with	NULL
m	NULL
«	NULL
BLTR	NULL
,	NULL
a	NULL
construct	NULL
which	NULL
lacks	NULL
functional	NULL
kB	NULL
sites	NULL
but	NULL
contains	NULL
C/EBP	NULL
sites	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
levels	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
loss	NULL
of	NULL
C/EBP	NULL
binding	NULL
sites	NULL
,	NULL
rather	NULL
than	NULL
loss	NULL
of	NULL
other	NULL
sequences	NULL
,	NULL
caused	NULL
the	NULL
observed	NULL
decrease	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
and	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
HIV-1	NULL
C/EBP	NULL
binding	NULL
sites	NULL
were	NULL
functionally	NULL
equivalent	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-205ALTR	NULL
.	NULL

The	NULL
two	NULL
3	NULL
'	NULL
C/EBP	NULL
sites	NULL
(	NULL
C2	NULL
[	NULL
-178	NULL
to	NULL
-159	NULL
bp	NULL
]	NULL
and	NULL
C3	NULL
[	NULL
-120	NULL
to	NULL
-109	NULL
were	NULL
mutated	NULL
by	NULL
PCR	NULL
;	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
mutant	NULL
sites	NULL
J.	NULL
ViroL	NULL
.	NULL

are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
confirmed	NULL
that	NULL
these	NULL
mutations	NULL
ablated	NULL
the	NULL
ability	NULL
of	NULL
recombinant	NULL
NF-IL6	NULL
to	NULL
bind	NULL
the	NULL
-178	NULL
to	NULL
-159	NULL
and	NULL
-120	NULL
to	NULL
-109	NULL
bp	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
site-directed	NULL
mutations	NULL
were	NULL
then	NULL
tested	NULL
by	NULL
transfection	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

Mutants	NULL
containing	NULL
single	NULL
mutations	NULL
at	NULL
either	NULL
site	NULL
had	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
construct	NULL
containing	NULL
mutations	NULL
in	NULL
both	NULL
C/EBP	NULL
binding	NULL
sites	NULL
(	NULL
mC2,3LTR	NULL
)	NULL
had	NULL
activity	NULL
which	NULL
was	NULL
decreased	NULL
by	NULL
70	NULL
%	NULL
and	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
of	NULL
the	NULL
truncated	NULL
construct	NULL
(	NULL
-109ALTR	NULL
)	NULL
lacking	NULL
all	NULL
C/EBP	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
of	NULL
the	NULL
truncations	NULL
and	NULL
site-directed	NULL
mutations	NULL
are	NULL
consistent	NULL
and	NULL
show	NULL
that	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
full	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
both	NULL
single	NULL
mutations	NULL
,	NULL
mC2LTR	NULL
and	NULL
mC3LTR	NULL
,	NULL
show	NULL
wild-type	NULL
activity	NULL
,	NULL
the	NULL
two	NULL
3	NULL
'	NULL
C/EBP	NULL
binding	NULL
sites	NULL
appear	NULL
to	NULL
be	NULL
functionally	NULL
equivalent	NULL
.	NULL

Following	NULL
activation	NULL
of	NULL
U937	NULL
cells	NULL
,	NULL
one	NULL
C/EBP	NULL
site	NULL
is	NULL
required	NULL
for	NULL
full	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
but	NULL
not	NULL
for	NULL
induction	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
.	NULL

Transcription	NULL
from	NULL
the	NULL
truncated	NULL
and	NULL
mutated	NULL
HIV-1	NULL
LTR	NULL
constructs	NULL
was	NULL
also	NULL
determined	NULL
after	NULL
the	NULL
transfected	NULL
U937	NULL
cells	NULL
were	NULL
activated	NULL
and	NULL
induced	NULL
to	NULL
differentiate	NULL
by	NULL
treatment	NULL
with	NULL
LPS	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Following	NULL
LPS-PMA	NULL
stimulation	NULL
,	NULL
transcription	NULL
from	NULL
the	NULL
-109ALTR	NULL
and	NULL
mC2,3LTR	NULL
constructs	NULL
was	NULL
dramatically	NULL
reduced	NULL
;	NULL
it	NULL
was	NULL
approximately	NULL
26	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
LTR	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
we	NULL
note	NULL
that	NULL
all	NULL
constructs	NULL
,	NULL
even	NULL
-93ALTR	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
three	NULL
C/EBP	NULL
sites	NULL
as	NULL
well	NULL
as	NULL
the	NULL
two	NULL
kB	NULL
sites	NULL
,	NULL
and	NULL
m	NULL
«	NULL
kBLTR	NULL
showed	NULL
activation-dependent	NULL
induction	NULL
in	NULL
the	NULL
range	NULL
of	NULL
six-	NULL
to	NULL
eightfold	NULL
after	NULL
LPS-PMA	NULL
treatment	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
for	NULL
these	NULL
results	NULL
is	NULL
that	NULL
there	NULL
exist	NULL
undetected	NULL
C/EBP	NULL
sites	NULL
within	NULL
the	NULL
HIV	NULL
LTR	NULL
.	NULL

However	NULL
,	NULL
no	NULL
C/EBP	NULL
sites	NULL
were	NULL
found	NULL
by	NULL
EMSAs	NULL
using	NULL
probes	NULL
that	NULL
spanned	NULL
the	NULL
-109	NULL
to	NULL
+78	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
to	NULL
bind	NULL
recombinant	NULL
NF-IL6	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

LPS	NULL
and	NULL
PMA	NULL
act	NULL
through	NULL
different	NULL
signal	NULL
transduction	NULL
pathways	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
59	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
C/EBP	NULL
sites	NULL
were	NULL
important	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
by	NULL
more	NULL
specific	NULL
stimuli	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
IL-6	NULL
,	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
PMA	NULL
plus	NULL
LPS	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
LTR	NULL
,	NULL
-205ALTR	NULL
,	NULL
-109ALTR	NULL
,	NULL
and	NULL
mC2,3LTR	NULL
constructs	NULL
were	NULL
induced	NULL
by	NULL
similar	NULL
amounts	NULL
in	NULL
response	NULL
to	NULL
each	NULL
treatment	NULL
.	NULL

Activating	NULL
U937	NULL
cells	NULL
with	NULL
either	NULL
IL-6	NULL
or	NULL
LPS	NULL
alone	NULL
induced	NULL
these	NULL
constructs	NULL
by	NULL
three	NULL
to	NULL
fivefold	NULL
,	NULL
whereas	NULL
treatments	NULL
involving	NULL
PMA	NULL
resulted	NULL
in	NULL
at	NULL
least	NULL
a	NULL
sevenfold	NULL
increase	NULL
in	NULL
transcription	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
constructs	NULL
lacking	NULL
NF-kB	NULL
sites	NULL
,	NULL
m	NULL
«	NULL
kBLTR	NULL
and	NULL
-93ALTR	NULL
,	NULL
were	NULL
reduced	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
individual	NULL
activators	NULL
although	NULL
not	NULL
by	NULL
PMA	NULL
plus	NULL
LPS	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
induction	NULL
was	NULL
observed	NULL
with	NULL
-93ALTR	NULL
in	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
IL-6	NULL
or	NULL
LPS	NULL
,	NULL
and	NULL
only	NULL
a	NULL
threefold	NULL
activation	NULL
of	NULL
both	NULL
-93ALTR	NULL
and	NULL
mkBLTR	NULL
was	NULL
observed	NULL
following	NULL
PMA	NULL
treatment	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
data	NULL
show	NULL
that	NULL
C/EBP	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
elevated	NULL
levels	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
following	NULL
activation	NULL
but	NULL
that	NULL
transcription	NULL
from	NULL
crippled	NULL
promoters	NULL
lacking	NULL
C/EBP	NULL
sites	NULL
is	NULL
still	NULL
inducible	NULL
.	NULL

DISCUSSION	NULL
The	NULL
studies	NULL
reported	NULL
here	NULL
establish	NULL
for	NULL
the	NULL
first	NULL
time	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
C/EBP	NULL
proteins	NULL
and	NULL
C/EBP	NULL
binding	NULL
sites	NULL
for	NULL
basal	NULL
and	NULL
activated	NULL
levels	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
endogenous	NULL
C/EBP	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
both	NULL
before	NULL
and	NULL
after	NULL
cellular	NULL
activation	NULL
and	NULL
differentiation	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
a	NULL
functional	NULL
requirement	NULL
for	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
A	NULL
C/EBP	NULL
C/EBP	NULL
C/EBP	NULL
«	NULL
8	NULL
Sp1	NULL
[	NULL
___	NULL
|_	NULL
A	NULL
elm	NULL
©	NULL
LTR	NULL
-205ALTR	NULL
158ALTR	NULL
-109ALTR	NULL
CHR	NULL
__	NULL
-93ALTR	NULL
E	NULL
_-__EC	NULL
BX	NULL
m	NULL
_	NULL
mxBLTR	NULL
C-	NULL
KX	NULL
FPAPR®RK	NULL
OJ	NULL
C-OH	NULL
C	NULL
C/EBP	NULL
PROTEINS	NULL
REGULATE	NULL
THE	NULL
HIV-1	NULL
LTR	NULL
5341	NULL
__	NULL
Y	NULL
__	NULL
j	NULL
»	NULL
Cc23LTR	NULL
0	NULL
B	NULL
Site	NULL
C2	NULL
Site	NULL
C3	NULL
mC2	NULL
TGCAGGGG~-	NULL
mC3	NULL
CAGCTG	NULL
C/EBP	NULL
AGCATTTCATCACACGT	NULL
GAGCTTGCTACAAG	NULL
-205	NULL
\W	NULL
|	NULL
j/a	NULL
C/EBP	NULL
c/eBp	NULL
xB	NULL
(	NULL
-170	NULL
)	NULL
(	NULL
-110	NULL
)	NULL
C	NULL
HIV-1	NULL
LTR	NULL
M2,3	NULL
LTR	NULL
rNF-IL6	NULL
ACT	NULL
(	NULL
+110	NULL
)	NULL
TCAAGAACTGACATCGACCTTGCTACAAAG	NULL
\_	NULL
__	NULL
jﬁ	NULL
‘	NULL
a.	NULL
to	NULL
_.	NULL
x	NULL
ah	NULL
*	NULL
``	NULL
se	NULL
&	NULL
c	NULL
®	NULL
&	NULL
%	NULL
#	NULL
w	NULL
ae	NULL
alk	NULL
g_	NULL
_	NULL
fire	NULL
#	NULL
o	NULL
a	NULL
$	NULL
§	NULL
i	NULL
$	NULL
5	NULL
i=	NULL
a	NULL
w	NULL
g	NULL
$	NULL
3	NULL
$	NULL
--	NULL
(	NULL
'	NULL
}	NULL
%	NULL
0	NULL
s	NULL
0	NULL
La	NULL
e	NULL
NEMC®	NULL
ne	NULL
ta	NULL
:	NULL
~	NULL
rk	NULL
Therefore	NULL
,	NULL
at	NULL
least	NULL
three	NULL
families	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
C/EBP	NULL
,	NULL
NF-kB/rel	NULL
,	NULL
and	NULL
Sp1	NULL
,	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
monocytes/macrophages	NULL
,	NULL
and	NULL
members	NULL
of	NULL
two	NULL
of	NULL
these	NULL
families	NULL
,	NULL
C/EBP	NULL
and	NULL
are	NULL
induced	NULL
upon	NULL
activation	NULL
of	NULL
monocytes/macrophages	NULL
(	NULL
22	NULL
,	NULL
37	NULL
,	NULL
40	NULL
,	NULL
46	NULL
,	NULL
51	NULL
)	NULL
.	NULL

The	NULL
_	NULL
0.5	NULL
1	NULL
1.5	NULL
2	NULL
2.5	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
SP1	NULL
_	NULL
SP1	NULL
SP1	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

C/EBP	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
basal	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
mg	NULL
of	NULL
various	NULL
truncated	NULL
and	NULL
mutated	NULL
LTR	NULL
constructs	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
an	NULL
average	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
using	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
DNA	NULL
preparations	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
1	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
C/EBP	NULL
sites	NULL
.	NULL

Altered	NULL
bases	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
wild-type	NULL
HIV-1	NULL
LTR	NULL
sequences	NULL
.	NULL

Numbers	NULL
in	NULL
parentheses	NULL
represent	NULL
the	NULL
central	NULL
base	NULL
pairs	NULL
in	NULL
the	NULL
recognition	NULL
sequences	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Mutations	NULL
disrupt	NULL
sequence-specific	NULL
binding	NULL
of	NULL
NF-IL6	NULL
.	NULL

Probes	NULL
were	NULL
generated	NULL
with	NULL
either	NULL
the	NULL
HIV	NULL
LTR	NULL
or	NULL
mC2,3LTR	NULL
and	NULL
incubated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
bacterially	NULL
expressed	NULL
rat	NULL
NF-IL6	NULL
(	NULL
rNF-IL6	NULL
)	NULL
.	NULL

Following	NULL
binding	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
DNase	NULL
I.	NULL
C/EBP	NULL
protein	NULL
NF-IL6	NULL
may	NULL
have	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
monocytes	NULL
,	NULL
since	NULL
it	NULL
can	NULL
bind	NULL
the	NULL
HIV-1	NULL
LTR	NULL
and	NULL
is	NULL
the	NULL
only	NULL
C/EBP	NULL
family	NULL
protein	NULL
which	NULL
is	NULL
induced	NULL
during	NULL
monocyte	NULL
differentiation	NULL
(	NULL
37	NULL
,	NULL
50	NULL
,	NULL
58	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Role	NULL
of	NULL
C/EBP	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

A	NULL
series	NULL
of	NULL
truncated	NULL
and	NULL
mutated	NULL
HIV-1	NULL
LTR	NULL
constructs	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
C/EBP	NULL
binding	NULL
sites	NULL
.	NULL

Our	NULL
results	NULL
obtained	NULL
by	NULL
using	NULL
these	NULL
constructs	NULL
are	NULL
generally	NULL
consistent	NULL
with	NULL
results	NULL
obtained	NULL
by	NULL
other	NULL
groups	NULL
who	NULL
performed	NULL
mutational	NULL
analyses	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
fibroblasts	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
monocytic	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
primary	NULL
monocytes	NULL
(	NULL
8	NULL
,	NULL
17	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
30	NULL
,	NULL
34	NULL
,	NULL
36	NULL
,	NULL
49	NULL
,	NULL
52	NULL
,	NULL
54	NULL
,	NULL
65	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
are	NULL
the	NULL
first	NULL
to	NULL
test	NULL
directly	NULL
and	NULL
systematically	NULL
the	NULL
importance	NULL
of	NULL
C/EBP	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
site	NULL
is	NULL
required	NULL
for	NULL
optimum	NULL
LTR	NULL
transcription	NULL
in	NULL
undifferentiated	NULL
U937	NULL
cells	NULL
and	NULL
for	NULL
high	NULL
levels	NULL
of	NULL
transcription	NULL
following	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Spacing	NULL
of	NULL
the	NULL
C/EBP	NULL
site	NULL
relative	NULL
to	NULL
the	NULL
NF-kB	NULL
and	NULL
Spl	NULL
sites	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
,	NULL
since	NULL
LTRs	NULL
retaining	NULL
either	NULL
the	NULL
-169	NULL
bp	NULL
C/EBP	NULL
site	NULL
or	NULL
the	NULL
-110	NULL
bp	NULL
site	NULL
showed	NULL
similar	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
6	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
,	NULL
however	NULL
,	NULL
that	NULL
5342	NULL
HENDERSON	NULL
ET	NULL
AL	NULL
.	NULL

C/EBP	NULL
_	NULL
C/EBP	NULL
C/EBP	NULL
«	NULL
B	NULL
Spi	NULL
L_________	NULL
&	NULL
_	NULL
50	NULL
BZ	NULL
M	NULL
|___	NULL
_s	NULL
_	NULL
PH	NULL
WMA	NULL
__	NULL
i	NULL
-	NULL
>	NULL
0saALTR	NULL
[	NULL
FHR	NULL
J	NULL
-1i5saltR	NULL
j	NULL
-109ALTR	NULL
CHM	NULL
~~	NULL
-~	NULL
B	NULL
BRA	NULL
,	NULL
mxBLTR	NULL
f	NULL
B	NULL
C	NULL
--	NULL
R	NULL
O	NULL
(	NULL
-CO	NULL
BH	NULL
RHR	NULL
»	NULL
Cs	NULL
``	NULL
r	NULL
&	NULL
[	NULL
__	NULL
K	NULL
mo	NULL
-93AL	NULL
TR	NULL
PRE	NULL
»	NULL
C2,3L.TAR§	NULL
J.	NULL
ViroL	NULL
.	NULL

UNSTIMULATED	NULL
0	NULL
-	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
18	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

C/EBP	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
following	NULL
LPS-PMA	NULL
activation	NULL
but	NULL
are	NULL
not	NULL
necessary	NULL
for	NULL
transcriptional	NULL
induction	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
various	NULL
LTR	NULL
constructs	NULL
and	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
pg	NULL
of	NULL
LPS	NULL
and	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
24	NULL
h.	NULL
Each	NULL
bar	NULL
represents	NULL
an	NULL
average	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
using	NULL
three	NULL
or	NULL
more	NULL
independent	NULL
plasmid	NULL
preparations	NULL
.	NULL

when	NULL
the	NULL
sequences	NULL
of	NULL
different	NULL
HIV-1	NULL
strains	NULL
are	NULL
compared	NULL
,	NULL
the	NULL
-110	NULL
bp	NULL
C/EBP	NULL
site	NULL
,	NULL
which	NULL
is	NULL
adjacent	NULL
to	NULL
the	NULL
NF-KB	NULL
sites	NULL
,	NULL
is	NULL
more	NULL
highly	NULL
conserved	NULL
than	NULL
the	NULL
-169	NULL
bp	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
may	NULL
be	NULL
that	NULL
although	NULL
our	NULL
transfection	NULL
experiments	NULL
did	NULL
not	NULL
reveal	NULL
a	NULL
functional	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
3	NULL
'	NULL
C/EBP	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
overall	NULL
viral	NULL
growth	NULL
,	NULL
the	NULL
-110	NULL
bp	NULL
site	NULL
is	NULL
more	NULL
important	NULL
.	NULL

The	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
from	NULL
-340	NULL
to	NULL
-158	NULL
bp	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
two	NULL
5	NULL
'	NULL
C/EBP	NULL
binding	NULL
sites	NULL
,	NULL
has	NULL
been	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
19	NULL
,	NULL
21	NULL
,	NULL
31	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
experiments	NULL
in	NULL
which	NULL
sequences	NULL
in	NULL
this	NULL
region	NULL
have	NULL
been	NULL
deleted	NULL
or	NULL
mutated	NULL
have	NULL
suggested	NULL
that	NULL
this	NULL
region	NULL
negatively	NULL
regulates	NULL
the	NULL
LTR	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
(	NULL
17	NULL
,	NULL
31	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
this	NULL
region	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
more	NULL
viral	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
monocytes/macrophages	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
these	NULL
reports	NULL
,	NULL
since	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
produced	NULL
a	NULL
modest	NULL
increase	NULL
in	NULL
HIV-1	NULL
LTR-driven	NULL
transcription	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
experiments	NULL
of	NULL
Tesmer	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
C/EBP	NULL
sites	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
negative	NULL
regulation	NULL
in	NULL
T-cell	NULL
and	NULL
hepatocyte	NULL
lines	NULL
(	NULL
58	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
even	NULL
though	NULL
two	NULL
C/EBP	NULL
sites	NULL
lie	NULL
in	NULL
this	NULL
region	NULL
,	NULL
they	NULL
are	NULL
not	NULL
responsible	NULL
for	NULL
negative	NULL
regulation	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Inhibiting	NULL
the	NULL
function	NULL
of	NULL
C/EBP	NULL
TABLE	NULL
1	NULL
.	NULL

Fold	NULL
induction	NULL
following	NULL
different	NULL
treatments	NULL
``	NULL
Fold	NULL
induction	NULL
after	NULL
treatment	NULL
with	NULL
:	NULL
Construct	NULL
IL-6	NULL
LPS	NULL
PMA	NULL
LPS	NULL
+	NULL
PMA	NULL
LTR	NULL
5.5	NULL
#	NULL
1.3	NULL
2.5	NULL
£	NULL
0.5	NULL
10.3	NULL
+	NULL
0.4	NULL
12.8	NULL
+	NULL
1.2	NULL
-205ALTR	NULL
4.0	NULL
+	NULL
1.0	NULL
3.2	NULL
+	NULL
0.4	NULL
14.4	NULL
+	NULL
3.0	NULL
6.8	NULL
+	NULL
0.9	NULL
-109ALTR	NULL
ND	NULL
2.9	NULL
+	NULL
0.6	NULL
7.8	NULL
£	NULL
0.1	NULL
12.5	NULL
+	NULL
4.2	NULL
-I3ALTR	NULL
1.6	NULL
+	NULL
0.8	NULL
0.7	NULL
+	NULL
0.3	NULL
2.6	NULL
+	NULL
0.5	NULL
10.4	NULL
+	NULL
2.3	NULL
me	NULL
«	NULL
BLTR	NULL
ND	NULL
ND	NULL
3.0	NULL
+	NULL
1.0	NULL
6.0	NULL
+	NULL
0.5	NULL
mC2,3LTR	NULL
3.5	NULL
+	NULL
0.8	NULL
3.0	NULL
+	NULL
1.0	NULL
8.1	NULL
+	NULL
3.2	NULL
11.3	NULL
+	NULL
3.2	NULL
``	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
constructs	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IL-6	NULL
(	NULL
80	NULL
U/ml	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/m1	NULL
)	NULL
,	NULL
or	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
plus	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
data	NULL
represent	NULL
means	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

proteins	NULL
or	NULL
mutating	NULL
the	NULL
-169	NULL
bp	NULL
C/EBP	NULL
site	NULL
did	NULL
not	NULL
increase	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
U937	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
hepatocytes	NULL
have	NULL
different	NULL
strategies	NULL
for	NULL
both	NULL
the	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
and	NULL
these	NULL
different	NULL
strategies	NULL
may	NULL
be	NULL
reflected	NULL
in	NULL
the	NULL
expression	NULL
patterns	NULL
of	NULL
C/EBP	NULL
family	NULL
members	NULL
(	NULL
7	NULL
,	NULL
13	NULL
,	NULL
37	NULL
,	NULL
45	NULL
)	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
the	NULL
importance	NULL
of	NULL
other	NULL
sites	NULL
for	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
basic	NULL
helix-loop-helix	NULL
leucine	NULL
zipper	NULL
(	NULL
bHLHZIP	NULL
)	NULL
proteins	NULL
TFE3	NULL
and	NULL
USF	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
a	NULL
site	NULL
which	NULL
overlaps	NULL
the	NULL
-169	NULL
bp	NULL
C/EBP	NULL
site	NULL
(	NULL
14	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Data	NULL
from	NULL
our	NULL
laboratory	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
bHLHZIP	NULL
protein	NULL
TFE3	NULL
and	NULL
NF-IL6	NULL
can	NULL
not	NULL
bind	NULL
this	NULL
region	NULL
simultaneously	NULL
and	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
compete	NULL
for	NULL
binding	NULL
(	NULL
2a	NULL
)	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
the	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
TFE3	NULL
and	NULL
USF	NULL
is	NULL
not	NULL
induced	NULL
following	NULL
monocyte/macrophage	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
formally	NULL
possible	NULL
that	NULL
changes	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
bHLHZIP	NULL
proteins	NULL
relative	NULL
to	NULL
C/EBP	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
this	NULL
is	NULL
unlikely	NULL
,	NULL
since	NULL
mutations	NULL
which	NULL
ablate	NULL
the	NULL
-169	NULL
C/EBP	NULL
site	NULL
and	NULL
the	NULL
TFE3/USF	NULL
site	NULL
(	NULL
mC2LTR	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
when	NULL
another	NULL
C/EBP	NULL
site	NULL
was	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
bHLHZIP	NULL
proteins	NULL
may	NULL
not	NULL
be	NULL
important	NULL
regulators	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Role	NULL
of	NULL
C/EBP	NULL
proteins	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
C/EBP	NULL
proteins	NULL
and	NULL
at	NULL
least	NULL
one	NULL
C/EBP	NULL
site	NULL
are	NULL
required	NULL
for	NULL
full	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
U937	NULL
cells	NULL
after	NULL
activation	NULL
;	NULL
however	NULL
,	NULL
transcription	NULL
from	NULL
mutant	NULL
HIV-1	NULL
LTRs	NULL
lacking	NULL
C/EBP	NULL
sites	NULL
can	NULL
be	NULL
induced	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
,	NULL
LPS	NULL
,	NULL
IL-6	NULL
,	NULL
or	NULL
LPS	NULL
plus	NULL
PMA	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
mutant	NULL
LTRs	NULL
lacking	NULL
«	NULL
B	NULL
sites	NULL
could	NULL
be	NULL
induced	NULL
after	NULL
treatment	NULL
with	NULL
LPS	NULL
plus	NULL
PMA	NULL
,	NULL
although	NULL
they	NULL
were	NULL
poorly	NULL
or	NULL
only	NULL
partially	NULL
induced	NULL
upon	NULL
treatment	NULL
with	NULL
individual	NULL
agents	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
which	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-kB	NULL
is	NULL
required	NULL
for	NULL
full	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
after	NULL
cellular	NULL
activation	NULL
(	NULL
22	NULL
,	NULL
35	NULL
)	NULL
.	NULL

They	NULL
are	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
findings	NULL
of	NULL
Sakaguchi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
52	NULL
)	NULL
,	NULL
who	NULL
showed	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
functional	NULL
NF-kB	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
sites	NULL
.	NULL

The	NULL
data	NULL
of	NULL
Sakaguchi	NULL
et	NULL
al	NULL
.	NULL

suggested	NULL
that	NULL
cellular	NULL
activation	NULL
may	NULL
induce	NULL
HIV-1	NULL
transcription	NULL
through	NULL
an	NULL
alternative	NULL
pathway	NULL
by	NULL
increasing	NULL
activity	NULL
of	NULL
the	NULL
basal	NULL
transcriptional	NULL
machinery	NULL
(	NULL
52	NULL
)	NULL
.	NULL

While	NULL
our	NULL
data	NULL
show	NULL
that	NULL
an	NULL
HIV-1	NULL
LTR	NULL
lacking	NULL
C/EBP	NULL
sites	NULL
can	NULL
be	NULL
induced	NULL
,	NULL
they	NULL
do	NULL
not	NULL
show	NULL
whether	NULL
the	NULL
elevated	NULL
levels	NULL
of	NULL
NF-IL6	NULL
which	NULL
accompany	NULL
U937	NULL
cell	NULL
activation	NULL
are	NULL
important	NULL
for	NULL
induced	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
that	NULL
elevated	NULL
NF-IL6	NULL
plays	NULL
in	NULL
induction	NULL
of	NULL
HIV-1	NULL
transcription	NULL
because	NULL
elevation	NULL
of	NULL
NF-IL6	NULL
accompanies	NULL
monocyte/macrophage	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
could	NULL
be	NULL
important	NULL
in	NULL
overcoming	NULL
viral	NULL
latency	NULL
or	NULL
increasing	NULL
HIV-1	NULL
replication	NULL
in	NULL
macrophages	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
envision	NULL
three	NULL
models	NULL
for	NULL
the	NULL
role	NULL
of	NULL
NF-IL6	NULL
in	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
which	NULL
are	NULL
consistent	NULL
with	NULL
all	NULL
of	NULL
the	NULL
data	NULL
.	NULL

The	NULL
first	NULL
model	NULL
posits	NULL
that	NULL
although	NULL
C/EBP	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
in	NULL
monocytes/macrophages	NULL
,	NULL
basal	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
sufficient	NULL
for	NULL
mediating	NULL
induction	NULL
following	NULL
cellular	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
other	NULL
inducible	NULL
activators	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B/rel	NULL
proteins	NULL
would	NULL
be	NULL
limiting	NULL
and	NULL
thus	NULL
required	NULL
for	NULL
the	NULL
inductive	NULL
response	NULL
,	NULL
whereas	NULL
increases	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
NF-IL6	NULL
would	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
HIV-1	NULL
LTR	NULL
induction	NULL
following	NULL
cellular	NULL
activation	NULL
.	NULL

A	NULL
second	NULL
model	NULL
is	NULL
that	NULL
increased	NULL
NF-IL6	NULL
does	NULL
induce	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
but	NULL
can	NULL
be	NULL
functionally	NULL
redundant	NULL
with	NULL
other	NULL
mechanisms	NULL
such	NULL
as	NULL
increases	NULL
in	NULL
NF-	NULL
proteins	NULL
(	NULL
22	NULL
,	NULL
35	NULL
)	NULL
or	NULL
basal	NULL
transcription	NULL
factors	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Our	NULL
cotransfection	NULL
and	NULL
cell	NULL
activation	NULL
assays	NULL
may	NULL
not	NULL
be	NULL
sufficiently	NULL
sensitive	NULL
to	NULL
distinguish	NULL
the	NULL
apparent	NULL
redundancy	NULL
of	NULL
these	NULL
effects	NULL
although	NULL
in	NULL
vivo	NULL
each	NULL
could	NULL
be	NULL
important	NULL
in	NULL
particular	NULL
physiological	NULL
situations	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
response	NULL
to	NULL
different	NULL
combinations	NULL
of	NULL
activation	NULL
signals	NULL
or	NULL
different	NULL
cellular	NULL
microenvironments	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
macrophages	NULL
from	NULL
mice	NULL
in	NULL
which	NULL
the	NULL
NF-IL6	NULL
gene	NULL
was	NULL
disrupted	NULL
by	NULL
gene	NULL
targeting	NULL
display	NULL
normal	NULL
induction	NULL
for	NULL
most	NULL
cytokines	NULL
(	NULL
57	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
functional	NULL
redundancy	NULL
of	NULL
transcription	NULL
activators	NULL
present	NULL
after	NULL
cellular	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
elevated	NULL
NF-IL6	NULL
would	NULL
be	NULL
important	NULL
for	NULL
HIV-1	NULL
induction	NULL
in	NULL
some	NULL
but	NULL
not	NULL
all	NULL
circumstances	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
increased	NULL
concentrations	NULL
of	NULL
NF-IL6	NULL
are	NULL
important	NULL
for	NULL
HIV-1	NULL
LTR	NULL
induction	NULL
in	NULL
vivo	NULL
but	NULL
there	NULL
is	NULL
an	NULL
apparent	NULL
site	NULL
independence	NULL
in	NULL
our	NULL
assay	NULL
because	NULL
of	NULL
protein-protein	NULL
associations	NULL
.	NULL

These	NULL
protein-protein	NULL
associations	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
functionally	NULL
important	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
.	NULL

In	NULL
transiently	NULL
transfected	NULL
cells	NULL
which	NULL
have	NULL
been	NULL
activated	NULL
,	NULL
elevated	NULL
levels	NULL
of	NULL
NF-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B/rel	NULL
proteins	NULL
may	NULL
be	NULL
sufficient	NULL
to	NULL
allow	NULL
their	NULL
association	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
their	NULL
cognate	NULL
DNA	NULL
binding	NULL
sites	NULL
,	NULL
with	NULL
DNA-bound	NULL
transcription	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
Sp1	NULL
or	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
,	NULL
leading	NULL
to	NULL
increased	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
.	NULL

This	NULL
suggestion	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
showing	NULL
functional	NULL
association	NULL
between	NULL
NF-IL6	NULL
and	NULL
other	NULL
transcription	NULL
activators	NULL
.	NULL

NF-IL6	NULL
interacts	NULL
physically	NULL
with	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
NF-kB	NULL
subunits	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
29	NULL
,	NULL
33	NULL
,	NULL
38	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
p65	NULL
appears	NULL
to	NULL
increase	NULL
the	NULL
binding	NULL
of	NULL
NF-IL6	NULL
to	NULL
C/EBP	NULL
binding	NULL
sites	NULL
,	NULL
suggesting	NULL
that	NULL
p65	NULL
can	NULL
stabilize	NULL
NF-IL6	NULL
complexes	NULL
(	NULL
56	NULL
)	NULL
.	NULL

C/EBP	NULL
proteins	NULL
or	NULL
C/EBP-NF-	NULL
«	NULL
B	NULL
complexes	NULL
may	NULL
also	NULL
associate	NULL
with	NULL
DNA-bound	NULL
Sp1	NULL
.	NULL

A	NULL
physical	NULL
and	NULL
functional	NULL
association	NULL
between	NULL
NF-kB	NULL
and	NULL
Spl	NULL
has	NULL
been	NULL
recently	NULL
reported	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
this	NULL
model	NULL
,	NULL
increased	NULL
levels	NULL
of	NULL
NF-IL6	NULL
would	NULL
be	NULL
important	NULL
for	NULL
increased	NULL
HIV-1	NULL
LTR	NULL
activity	NULL
in	NULL
vivo	NULL
,	NULL
but	NULL
protein-protein	NULL
associations	NULL
with	NULL
DNA-bound	NULL
activators	NULL
would	NULL
confer	NULL
binding	NULL
site	NULL
independence	NULL
in	NULL
our	NULL
assay	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
work	NULL
establishes	NULL
a	NULL
role	NULL
for	NULL
C/EBP	NULL
proteins	NULL
in	NULL
HIV-1	NULL
LTR	NULL
transcription	NULL
in	NULL
monocytes/macrophages	NULL
.	NULL

To	NULL
C/EBP	NULL
PROTEINS	NULL
REGULATE	NULL
THE	NULL
HIV-1	NULL
LTR	NULL
5343	NULL
determine	NULL
which	NULL
of	NULL
the	NULL
aforementioned	NULL
models	NULL
for	NULL
how	NULL
elevated	NULL
NF-IL6	NULL
may	NULL
act	NULL
is	NULL
valid	NULL
,	NULL
we	NULL
are	NULL
currently	NULL
altering	NULL
levels	NULL
of	NULL
endogenous	NULL
NF-IL6	NULL
by	NULL
means	NULL
other	NULL
than	NULL
cellular	NULL
activation	NULL
to	NULL
determine	NULL
whether	NULL
such	NULL
changes	NULL
affect	NULL
transcription	NULL
rates	NULL
of	NULL
latent	NULL
HIV-1	NULL
.	NULL

We	NULL
are	NULL
also	NULL
testing	NULL
the	NULL
ability	NULL
of	NULL
viruses	NULL
lacking	NULL
C/EBP	NULL
sites	NULL
to	NULL
be	NULL
induced	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Ruth	NULL
Connor	NULL
,	NULL
Jeremy	NULL
Luban	NULL
,	NULL
and	NULL
Gerald	NULL
Siu	NULL
for	NULL
valuable	NULL
discussion	NULL
and	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Gary	NULL
Nabel	NULL
for	NULL
the	NULL
m	NULL
«	NULL
BLTRCAT	NULL
construct	NULL
.	NULL

A.J.H	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Aaron	NULL
Diamond	NULL
Foundation	NULL
.	NULL

This	NULL
work	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
GM29361	NULL
and	NULL
GM44300	NULL
to	NULL
KL.C	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
T.	NULL
Osamu	NULL
,	NULL
S.	NULL
Kinoshita	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
'T	NULL
.	NULL

Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
Family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

127:25-50	NULL
.	NULL

2a	NULL
.	NULL

Artandi	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

3	NULL
.	NULL

Artandi	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Cooper	NULL
,	NULL
A.	NULL
Shrivastava	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
basic	NULL
helix-loop-helix-zipper	NULL
domain	NULL
of	NULL
TFE3	NULL
mediates	NULL
enhancer-promoter	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7704-7716	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NFB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-180	NULL
.	NULL

5	NULL
.	NULL

Breen	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
A.	NULL
R.	NULL
Rezai	NULL
,	NULL
K.	NULL
Nakajima	NULL
,	NULL
G.	NULL
N.	NULL
Beall	NULL
,	NULL
R.	NULL
T.	NULL
Mitsuyasu	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
O.	NULL
Martinez-Maza	NULL
.	NULL

1990	NULL
.	NULL

Infection	NULL
with	NULL
HIV	NULL
is	NULL
associated	NULL
with	NULL
elevated	NULL
IL-6	NULL
levels	NULL
and	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:480-484	NULL
.	NULL

6	NULL
.	NULL

Cao	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
Umek	NULL
,	NULL
and	NULL
S.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
during	NULL
adipose	NULL
conversion	NULL
of	NULL
3T3-L1	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

51538-1552	NULL
.	NULL

7	NULL
.	NULL

Chang	NULL
,	NULL
C.-J	NULL
.	NULL

,	NULL
T.	NULL
Chen	NULL
,	NULL
H.-Y	NULL
.	NULL

Lei	NULL
,	NULL
D.-S.	NULL
Chen	NULL
,	NULL
and	NULL
S.-C.	NULL
Lee	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
AGP-DBP	NULL
,	NULL
that	NULL
belongs	NULL
to	NULL
members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6642-6653	NULL
.	NULL

8	NULL
.	NULL

Chang	NULL
,	NULL
K.	NULL
,	NULL
W.	NULL
Liu	NULL
,	NULL
and	NULL
S.	NULL
Josephs	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
cellular	NULL
trans-activating	NULL
activities	NULL
in	NULL
two	NULL
different	NULL
promonocytic	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

Cancer	NULL
Lett	NULL
.	NULL

60:75-83	NULL
.	NULL

9	NULL
.	NULL

Chayt	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
M.	NULL
E.	NULL
Harper	NULL
,	NULL
L	NULL
M.	NULL
Marselle	NULL
,	NULL
E.	NULL
B.	NULL
Lewis	NULL
,	NULL
R.	NULL
M.	NULL
Rose	NULL
,	NULL
J.	NULL
M.	NULL
Oleske	NULL
,	NULL
L.	NULL
G.	NULL
Epstein	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
HTLV-III	NULL
RNA	NULL
in	NULL
lungs	NULL
of	NULL
patients	NULL
with	NULL
AIDS	NULL
and	NULL
pulmonary	NULL
involvement	NULL
.	NULL

JAMA	NULL
256:2356-2359	NULL
.	NULL

10	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Preybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biological	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribo-nuclease	NULL
.	NULL

Biochemistry	NULL
18:5294-5298	NULL
.	NULL

11.	NULL
Cooper	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
J.	NULL
Henderson	NULL
,	NULL
S.	NULL
Artandi	NULL
,	NULL
N.	NULL
Avithal	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

Ig/EBP	NULL
inhibits	NULL
C/EBP	NULL
family	NULL
transcriptional	NULL
activators	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

12.	NULL
Cooper	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Berrier	NULL
,	NULL
C.	NULL
Roman	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1994	NULL
.	NULL

Limited	NULL
expression	NULL
of	NULL
C/EBP	NULL
family	NULL
proteins	NULL
during	NULL
B-lymphocyte	NULL
development	NULL
:	NULL
negative	NULL
regulator	NULL
Ig/EBP	NULL
predominates	NULL
early	NULL
and	NULL
activator	NULL
NF-IL6	NULL
is	NULL
induced	NULL
later	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5049-5058	NULL
.	NULL

13	NULL
.	NULL

Descombes	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
liver-enriched	NULL
transcriptional	NULL
activator	NULL
protein	NULL
,	NULL
LAP	NULL
,	NULL
and	NULL
a	NULL
transcriptional	NULL
inhibitory	NULL
protein	NULL
,	NULL
LIP	NULL
,	NULL
are	NULL
translated	NULL
from	NULL
the	NULL
same	NULL
mRNA	NULL
.	NULL

Cell	NULL
67:569-579	NULL
.	NULL

14	NULL
.	NULL

Di	NULL
Fagagna	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Marzio	NULL
,	NULL
M.	NULL
I.	NULL
Gutierrez	NULL
,	NULL
L.	NULL
Y.	NULL
Kang	NULL
,	NULL
A.	NULL
Falasch	NULL
,	NULL
and	NULL
M.	NULL
Giacea	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
and	NULL
functional	NULL
interactions	NULL
of	NULL
transcription	NULL
factor	NULL
USF	NULL
with	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2765-2775	NULL
.	NULL

15	NULL
.	NULL

Fauci	NULL
,	NULL
A	NULL
.	NULL

1993	NULL
.	NULL

Multifactorial	NULL
nature	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
dis-ease	NULL
:	NULL
implications	NULL
for	NULL
therapy	NULL
.	NULL

Science	NULL
262:1011-1018	NULL
.	NULL

16	NULL
.	NULL

Fauci	NULL
,	NULL
A.	NULL
S.	NULL
1988	NULL
.	NULL

The	NULL
human	NULL
immunodefeciency	NULL
virus	NULL
:	NULL
infectivity	NULL
and	NULL
mechanisms	NULL
of	NULL
pathogenesis	NULL
.	NULL

Science	NULL
239:480-484	NULL
.	NULL

17	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
K.	NULL
Wu	NULL
,	NULL
R.	NULL
Mitsuyasu	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1987	NULL
.	NULL

Interactions	NULL
of	NULL
cellular	NULL
proteins	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

63761-3770	NULL
.	NULL

18	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Markovits	NULL
,	NULL
B.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovie	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-II/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

19	NULL
.	NULL

Gaynor	NULL
,	NULL
R.	NULL
1992	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

AIDS	NULL
6:347-363	NULL
.	NULL

20	NULL
.	NULL

Green	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
I.	NULL
Chen	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
expression	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

1:169-175	NULL
.	NULL

21	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
1990	NULL
.	NULL

Regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8453-475	NULL
.	NULL

22	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folkes	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

5344	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

HENDERSON	NULL
ET	NULL
AL	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
339:70-73	NULL
.	NULL

Guilian	NULL
,	NULL
D.	NULL
,	NULL
K.	NULL
Vaca	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Noonan	NULL
.	NULL

1990	NULL
.	NULL

Secretion	NULL
of	NULL
neurotoxins	NULL
by	NULL
mononuclear	NULL
phagocytes	NULL
infected	NULL
with	NULL
HIV-1	NULL
.	NULL

Science	NULL
250:1593-1596	NULL
.	NULL

Koenig	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
E.	NULL
Gendelman	NULL
,	NULL
J.	NULL
N.	NULL
Orenstein	NULL
,	NULL
M.	NULL
C.	NULL
Dal	NULL
Canto	NULL
,	NULL
G.	NULL
H.	NULL
Pezeshkpour	NULL
,	NULL
M.	NULL
Yungbluth	NULL
,	NULL
F.	NULL
Janotta	NULL
,	NULL
A.	NULL
Aksamit	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
AIDS	NULL
virus	NULL
in	NULL
macrophages	NULL
in	NULL
brain	NULL
tissue	NULL
from	NULL
AIDS	NULL
patients	NULL
with	NULL
encephalopathy	NULL
.	NULL

Science	NULL
233:1089-1093	NULL
.	NULL

Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
W.	NULL
O'Brien	NULL
,	NULL
J.	NULL
Q.	NULL
Zhao	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1988	NULL
.	NULL

Cytokines	NULL
alter	NULL
production	NULL
of	NULL
HIV-1	NULL
from	NULL
primary	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Science	NULL
241:1673-1675	NULL
.	NULL

Krummel	NULL
,	NULL
B	NULL
.	NULL

1990	NULL
.	NULL

Dnasel	NULL
footprinting	NULL
,	NULL
p.	NULL
184-188	NULL
.	NULL

In	NULL
M.	NULL
Innis	NULL
,	NULL
D.	NULL
Gel-fand	NULL
,	NULL
J.	NULL
Sninsky	NULL
,	NULL
and	NULL
T.	NULL
White	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
PCR	NULL
protocol	NULL
,	NULL
a	NULL
guide	NULL
to	NULL
methods	NULL
and	NULL
applications	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Lahdevirta	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
P.	NULL
J.	NULL
Maury	NULL
,	NULL
A.	NULL
M.	NULL
Teppo	NULL
,	NULL
and	NULL
H.	NULL
Repo	NULL
.	NULL

1988	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
circulating	NULL
cachectin/tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
patients	NULL
with	NULL
acquired	NULL
immunodefeciency	NULL
syndrome	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

85:289	NULL
.	NULL

Landt	NULL
,	NULL
O.	NULL
,	NULL
H.-P.	NULL
Grunert	NULL
,	NULL
and	NULL
U.	NULL
Hahn	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
general	NULL
method	NULL
for	NULL
rapid	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Gene	NULL
96:125-128	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8145-8149	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Effects	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
mutations	NULL
on	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4115-4119	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Touzian	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
T.	NULL
Dorfman	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
repressive	NULL
sequence	NULL
within	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64	NULL
:	NULL
5226-5229	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Har-bor	NULL
,	NULL
N.Y.	NULL
Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NF-IL6	NULL
and	NULL
NF-kB	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193-10197	NULL
.	NULL

Moses	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Ibanez	NULL
,	NULL
R.	NULL
Gaynor	NULL
,	NULL
P.	NULL
Ghazal	NULL
,	NULL
and	NULL
J.	NULL
Nelson	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
role	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
control	NULL
elements	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
basal	NULL
and	NULL
Tat-mediated	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
primary	NULL
human	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:298-307	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nakanishi	NULL
,	NULL
Y.	NULL
,	NULL
Y.	NULL
Masamune	NULL
,	NULL
and	NULL
N.	NULL
Kobayashi	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
cis-acting	NULL
element	NULL
that	NULL
controls	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
DNA	NULL
,	NULL
depending	NULL
on	NULL
cell	NULL
type	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6334-6338	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
S.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
79:460-466	NULL
.	NULL

Nishio	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
interleukin-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
synergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
rat	NULL
al-acid	NULL
glycoprotein	NULL
gene	NULL
via	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1854-1862	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795-798	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
E.	NULL
Pascal	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
interaction	NULL
between	NULL
the	NULL
DNA-binding	NULL
domains	NULL
of	NULL
relA	NULL
(	NULL
p63	NULL
)	NULL
and	NULL
Spl	NULL
mediates	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gene	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6570-6583	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

Perrin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
Gilliland	NULL
.	NULL

1990	NULL
.	NULL

Site-Specific	NULL
mutagenesis	NULL
using	NULL
asymmetric	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
a	NULL
simple	NULL
mutant	NULL
primer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:7433	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
W.	NULL
C.	NULL
Timmer	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Interleukin	NULL
6	NULL
induces	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
in	NULL
infected	NULL
monocytic	NULL
cells	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
by	NULL
transcriptional	NULL
and	NULL
post-transcrip-tional	NULL
mechanisms	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:151-158	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
J.	NULL
H.	NULL
Kehrl	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
functions	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:782-785	NULL
.	NULL

Poli	NULL
,	NULL
V.	NULL
,	NULL
F.	NULL
Mancini	NULL
,	NULL
and	NULL
R.	NULL
Cortese	NULL
.	NULL

1990	NULL
.	NULL

IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
63:643-653	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Lipo-polysaccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulator	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:253-261	NULL
.	NULL

Roman	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
S.	NULL
Platero	NULL
,	NULL
J.	NULL
Shuman	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1990	NULL
.	NULL

Ig/EBP-1	NULL
:	NULL
an	NULL
ubiquitously	NULL
expressed	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
C/EBP	NULL
and	NULL
heterodimerizes	NULL
with	NULL
C/EBP	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1404-1415	NULL
.	NULL

Ron	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
Habener	NULL
.	NULL

1992	NULL
.	NULL

CHOP	NULL
,	NULL
a	NULL
novel	NULL
developmentally	NULL
regulated	NULL
nuclear	NULL
protein	NULL
that	NULL
dimerizes	NULL
with	NULL
transcription	NULL
factors	NULL
C/EBP	NULL
and	NULL
LAP	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
dominant-negative	NULL
inhibitor	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6439-453	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
location	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
IIH	NULL
(	NULL
HTLV-III/LAV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Cell	NULL
41:813-823	NULL
.	NULL

Rossol	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
Gianni	NULL
,	NULL
R.	NULL
Rossol-Voth	NULL
,	NULL
H.	NULL
Gallati	NULL
,	NULL
W.	NULL
Muller	NULL
,	NULL
and	NULL
K.	NULL
Mey-erzum	NULL
Buschenfelde	NULL
.	NULL

1992	NULL
.	NULL

Cytokine-mediated	NULL
regulation	NULL
of	NULL
monocyte/macrophage	NULL
cytotoxicity	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Med	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

181:267-281	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
F.	NULL
Boulerice	NULL
,	NULL
S.	NULL
Caplan	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
NF-	NULL
«	NULL
B-like	NULL
activities	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
infection	NULL
of	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:751-763	NULL
.	NULL

Sakaguchi	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Zenzie-Gregory	NULL
,	NULL
J.	NULL
Groopman	NULL
,	NULL
S.	NULL
Smale	NULL
,	NULL
and	NULL
S.	NULL
Kim	NULL
.	NULL

1991	NULL
.	NULL

Alternative	NULL
pathway	NULL
for	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gene	NULL
expression	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
machinery	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5448-5456	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
miniextracts	NULL
``	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
M.	NULL
Dukovich	NULL
,	NULL
N.	NULL
Peter	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
HIV-1	NULL
LTR	NULL
by	NULL
T	NULL
cell	NULL
mitogens	NULL
and	NULL
trans-activator	NULL
protein	NULL
of	NULL
HTLV-I	NULL
.	NULL

Science	NULL
238:1575-1578	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
same	NULL
50-kDa	NULL
cellular	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
negative	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:8526-8530	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
C.	NULL
Cogswell	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Functional	NULL
and	NULL
physical	NULL
associations	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
C/EBP	NULL
family	NULL
members	NULL
:	NULL
a	NULL
Rel	NULL
domain-bZIP	NULL
interaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3964-3974	NULL
.	NULL

Tanaka	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
M.	NULL
Umemoto	NULL
,	NULL
Y.	NULL
Yoneda	NULL
,	NULL
N.	NULL
Shirafuji	NULL
,	NULL
H.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
S	NULL
tsu	NULL
,	NULL
N.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1995	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacteria	NULL
killing	NULL
and	NULL
tumor	NULL
cytotoxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
80:353-361	NULL
.	NULL

Tesmer	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
A.	NULL
Rajadhyaksha	NULL
,	NULL
J.	NULL
Babin	NULL
,	NULL
and	NULL
M.	NULL
Bina	NULL
.	NULL

1993	NULL
.	NULL

NF-IL6-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:7298-7302	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
lesson	NULL
in	NULL
family	NULL
values	NULL
.	NULL

Cell	NULL
80:529-532.	NULL
van	NULL
Zonneveld	NULL
,	NULL
A.~J	NULL
.	NULL

,	NULL
S.	NULL
A.	NULL
Curriden	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Loskutof	NULL
.	NULL

1988	NULL
.	NULL

Type	NULL
1	NULL
plasminogen	NULL
activator	NULL
inhibitor	NULL
gene	NULL
:	NULL
functional	NULL
analysis	NULL
and	NULL
glucocorticoid	NULL
regulation	NULL
of	NULL
its	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:5525-5529	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
Sigler	NULL
,	NULL
and	NULL
S.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Scissors-grip	NULL
model	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
a	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Science	NULL
246:911-916	NULL
.	NULL

Watkins	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
H.	NULL
H.	NULL
Dorn	NULL
,	NULL
W.	NULL
B.	NULL
Kelley	NULL
,	NULL
R.	NULL
C.	NULL
Armstrong	NULL
,	NULL
B.	NULL
J.	NULL
Potts	NULL
,	NULL
F.	NULL
Michaels	NULL
,	NULL
C.	NULL
V.	NULL
Kufta	NULL
,	NULL
and	NULL
M.	NULL
Dubois-Daleq	NULL
.	NULL

1990	NULL
.	NULL

Specific	NULL
tropism	NULL
of	NULL
HIV-1	NULL
for	NULL
microglial	NULL
cells	NULL
in	NULL
primary	NULL
human	NULL
brain	NULL
cultures	NULL
.	NULL

Science	NULL
249:549-553	NULL
.	NULL

Williams	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Cantwell	NULL
,	NULL
and	NULL
P.	NULL
Johnson	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
family	NULL
of	NULL
C/EBP	NULL
related	NULL
proteins	NULL
capable	NULL
of	NULL
forming	NULL
covalently	NULL
linked	NULL
leucine	NULL
zipper	NULL
dimers	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

51553-1567	NULL
.	NULL

Wu	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
Berk	NULL
.	NULL

1988	NULL
.	NULL

Constraints	NULL
on	NULL
spacing	NULL
between	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
a	NULL
simple	NULL
adenovirus	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2403-411	NULL
.	NULL

Zeichner	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
J.	NULL
Y.	NULL
H.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Alwine	NULL
.	NULL

1991	NULL
.	NULL

Linker-scanning	NULL
mutational	NULL
analysis	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:2436-2444	NULL
.	NULL

